Crossref
Correction: The role of Asprosin in the diagnosis of diabetic and non-diabetic patients with sepsis
Signa Vitae · 08.08.2026
DOI: 10.22514/sv.2026.041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Signa Vitae, online erschienen am 08.08.2026. Verfasst von Semra Aytürk Salt.
Themen: Sepsis
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Salt, S. A. (2026). Correction: The role of Asprosin in the diagnosis of diabetic and non-diabetic patients with sepsis. Signa Vitae. https://doi.org/10.22514/sv.2026.041
Vancouver
Salt SA. Correction: The role of Asprosin in the diagnosis of diabetic and non-diabetic patients with sepsis. Signa Vitae. 2026. doi:10.22514/sv.2026.041
BibTeX
@article{Salt2026,
author = {Salt, Semra Aytürk},
title = {Correction: The role of Asprosin in the diagnosis of diabetic and non-diabetic patients with sepsis},
journal = {Signa Vitae},
year = {2026},
doi = {10.22514/sv.2026.041}
}
EUVIMED